Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06114485 · ClinicalTrials.gov registry record · NA
Voice Activated Personal Assistant for Depression Among Older Adults
A NA study of Depression, Anxiety, sponsored by Northwestern University.
- Active
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06114485: Active NA study of Depression, Anxiety, sponsored by Northwestern University.
NCT06114485 is a NA study of Depression, Anxiety that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 80 participants, below the 423-participant average among 40 other Depression, Anxiety trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06114485, a NA study of Depression, Anxiety, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Participants will use Amazon Alexa to test a new voice-assisted program for mental health management. The participant will use this program to help with goal setting, reminders, and various other services. The participant may be supported by a caregiver, if available, or by research team member who will serve as a coach for the duration of the study to guide them with using the program. Participants will be asked to complete surveys and assessments about their experiences during the 12-week study period. Participants will be randomized into two groups: those who receive a guide to help them with utilization of the program to its fullest potential and those who do not receive that guide.
Primary Outcome
The Patient Health Questionnaire-9 (PHQ-9) PHQ-9 measures depression symptom severity on a scale of 0-27, with higher scores indicating greater symptom severity. The PHQ-9 measures depressive symptom severity on a scale of 0-27, with higher scores indicating greater severity
Conditions Studied
Interventions
- BEHAVIORAL VIPA Treatment Program
- BEHAVIORAL Alexa with Guidebook
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-12-04 |
| Est. Completion | 2025-10-31 |
| Phase | NA |
What the registry record for NCT06114485 still lists
NCT06114485 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 423-participant average among 40 other Depression, Anxiety trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Depression, Anxiety appearing as the primary indexed condition, and to 2 interventions - of which VIPA Treatment Program is the first listed.
NCT06114485 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06114485 about?
NCT06114485 is a clinical study titled "Voice Activated Personal Assistant for Depression Among Older Adults". Participants will use Amazon Alexa to test a new voice-assisted program for mental health management. The participant will use this program to help with goal setting, reminders, and various other services. The participant may be supported by a caregiver, if available, or by research team member who ...
What is the current status of trial NCT06114485?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-12-04. Estimated completion is 2025-10-31.
What conditions does trial NCT06114485 study?
This clinical trial studies the following conditions: Depression, Anxiety.
What interventions are being tested in trial NCT06114485?
The interventions under investigation include: VIPA Treatment Program (BEHAVIORAL), Alexa with Guidebook (BEHAVIORAL).
Who is sponsoring clinical trial NCT06114485?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06114485 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression, Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06114485's enrollment target sits among peer trials
80 29th of 40 higher than 12 of 40 other Depression, Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression, Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
-
Test of Target Engagement of Ambiguity Aversion
RECRUITING · NA
-
SUpport From PEeRs to Expand Access Study - Community
RECRUITING · NA
-
Building Connections
RECRUITING · NA
-
Just-In-Time Adaptive Interventions (JITAIs) in a Digital Mental Health Intervention for Middle-Aged and Older Adults With Chronic Pain
RECRUITING · NA
-
Harlem Strong Mental Health Coalition
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI